AccuBio

Developing, manufacturing, and commercializing in-vitro diagnostic test systems worldwide to enhance global health

[AccuBio @AccuBio_Ltd]

AccuBio was proud to support AHD training in Burundi, equipping healthcare workers from 30 facilities with practical skills in VISITECT® CD4 Advanced Disease, LF-LAM and CrAg testing to improve HIV diagnosis and patient care.

Huge thank you to the Ministry of Health, PNLS & ICAP

[AccuBio @AccuBio_Ltd]

AccuBio's VISITECT® CD4 Advanced Disease test is helping community health workers rapidly identify people living with advanced HIV disease, enabling earlier intervention and connecting patients to the care they need most.

Read More: https://t.co/7hHog0gBF9

[AccuBio @AccuBio_Ltd]

Designed for low-throughput and community-based healthcare settings, AccuBio's Biochemistry Analyser brings reliable clinical chemistry testing closer to the patient.

Learn more: https://t.co/XmVCa114eH

#Biochemistry #Diagnostics #PointOfCare #MedTech

[AccuBio @AccuBio_Ltd]

Decentralised care needs more than rapid results, it needs confidence in clinical decisions.

AccuBio’s Fluorescence Immunoassays & Readers deliver quantitative testing at the point of care, supporting faster triage and data-driven patient management.

#PointOfCare #Diagnostics

[AccuBio @AccuBio_Ltd]

AccuBio’s MHFA, Environmental & Social Committees hosted a fantastic event for Mental Health Awareness Week 💚

From litter picking to quizzes, the afternoon was a great reflection of our core value: #GrowTogether 🌱

[AccuBio @AccuBio_Ltd]

Recent events have demonstrated with hantavirus, access to reliable diagnostic tools remains important for responding to outbreaks.

AccuBio offers a professional use hantavirus test, which detects IgM antibodies, as part of our broader infectious disease portfolio.

#Hantavirus

[AccuBio @AccuBio_Ltd]

Robust sample collection devices are an essential part of point-of-collection screening for back-to-lab testing.

AccuBio’s collection devices are designed to enable effective sample collection and transport, giving you confidence throughout the process.

https://t.co/FpbiKfLqCU

[AccuBio @AccuBio_Ltd]

Point-of-collection substance misuse testing relies on rapid screening alongside robust, secure sample collection for back-to-lab confirmatory testing.

AccuBio offers rapid drugs of abuse testing alongside collection devices designed to transport for laboratory confirmation.

[AccuBio @AccuBio_Ltd]

AccuBio's rapid malaria test range enable the differential detection of P. faliciparum, P. vivax and other (Pan) malarial species antigens and antibodies.

✅ Visual read
✅ Results in 20 minutes
✅ Use across decentralised settings

Learn more: https://t.co/UbDAz8VPYs

[AccuBio @AccuBio_Ltd]

WHO data shows malaria remains a major global challenge, with 282 million cases in 2024.
Progress depends on timely, accurate diagnosis. Expanding access to reliable screening is key to effective detection and control.

https://t.co/ms5KvIHmqj

#Diagnostics #GlobalHealth #WMD2026

[AccuBio @AccuBio_Ltd]

This #WorldMalariaDay: Grasp the moment.

Malaria remains a major global health challenge, with hundreds of thousands of deaths each year.

Progress is fragile—early, accessible diagnostic screening is key.

#NowWeCanNowWeMust #ZeroMalaria #WMD2026

[AccuBio @AccuBio_Ltd]

From identifying nutrient deficiencies to diagnosing health conditions that impact metabolic processes.

AccuBio’s metabolism range supports the detection and monitoring of key biomarkers, for both self-testing and use in clinical settings.

Contact us: https://t.co/7b1sKcFFZS

[AccuBio @AccuBio_Ltd]

Improving reliable testing is key to reducing the global impact of TB infections.

AccuBio’s Tuberculosis test provides a simple and accessible solution for detecting TB.

• Results in 10 minutes
• Visual read
• Separate IgM and IgG results

Contact us: https://t.co/4r1baacZxu

[AccuBio @AccuBio_Ltd]

Tuberculosis is the leading cause of death from a single infectious agent, globally.

This year’s campaign theme — “Yes! We can end TB!” — highlights the collective effort needed to prevent, diagnose and treat tuberculosis worldwide.

#WorldTBDay #EndTB #Tuberculosis

[AccuBio @AccuBio_Ltd]

Diagnostic testing is evolving beyond the central laboratory.​

AccuBio’s CLIA-go Pro brings laboratory-quality performance to decentralised healthcare environments, enabling a broad range of clinical testing closer to the patient

Contact us: https://t.co/7b1sKcFFZS​

#CLIA

[AccuBio @AccuBio_Ltd]

AccuBio’s fluorescence immunoassay (FIA) solutions support decentralised testing across a wide range of clinical areas, including respiratory virus testing, prostate-specific antigen (PSA), HbA1c, thyroid function, vitamin deficiency and women’s health, enabling use in pharmacies

[AccuBio @AccuBio_Ltd]

Concerned about vitamin D deficiency?

Vitamin D plays an important role in supporting bone health, immune function and general wellbeing.

AccuBio’s Vitamin D self-test delivers visual results in just 15 minutes.

Contact us: https://t.co/7b1sKcFFZS

#VitaminD #SelfTesting

[AccuBio @AccuBio_Ltd]

AccuBio’s CLIA-go Pro system and comprehensive test menu delivers laboratory-quality analytical performance in near-patient and decentralised healthcare settings.

• Results in 15 minutes
• 40+ test menu

Contact us: https://t.co/7b1sKcFFZS

[AccuBio @AccuBio_Ltd]

Why test for just one respiratory virus?

COVID-19 isn't the only virus in circulation. Flu and RSV continue to spread during respiratory virus season.

AccuBio’s combination respiratory virus tests enable accurate identification of the causative virus from a single sample.

[AccuBio @AccuBio_Ltd]

AccuBio Vitamin B12 and Folate tests support vitamin deficiency testing in community healthcare settings.

• Results in 15 minutes
• High-sensitivity, quantitative Fluorescence Immunoassay
• Small benchtop instrument

Convenient, cost-effective Vitamin B12 and Folate testing.